Molina Healthcare Inc. (MOH)
NYSE: MOH
· Real-Time Price · USD
167.28
7.65 (4.79%)
At close: Aug 15, 2025, 3:11 PM
Molina Healthcare Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 11.43B | 11.15B | 10.5B | 10.34B | 9.86B | 9.93B | 9.05B | 8.55B | 8.33B | 8.15B | 8.22B | 7.93B | 8.05B | 7.77B | 7.41B | 7.04B | 6.8B | 6.52B |
Cost of Revenue | 9.87B | 9.87B | 9.39B | 9.15B | 8.67B | 8.71B | 8.01B | 7.48B | 7.21B | 7.04B | 7.22B | 6.97B | 7.09B | 6.77B | 6.57B | 6.25B | 6B | 5.66B |
Gross Profit | -1.28B | 1.28B | 1.11B | 1.19B | 1.19B | 1.22B | 1.04B | 1.07B | 1.12B | 1.11B | 1B | 956M | 967M | 999M | 836M | 787M | 796M | 861M |
Operating Income | 373M | 433M | 380M | 467M | 434M | 426M | 316M | 359M | 443M | 455M | 313M | 335M | 361M | 372M | 191M | 221M | 273M | 335M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 325M | 390M | 346M | 438M | 406M | 399M | 289M | 332M | 416M | 427M | 78M | 307M | 334M | 344M | 136M | 191M | 243M | 305M |
Net Income | 255M | 298M | 251M | 326M | 301M | 301M | 216M | 245M | 309M | 321M | 56M | 230M | 248M | 258M | 103M | 143M | 185M | 228M |
Selling & General & Admin | 711M | 774M | 665M | 676M | 691M | 711M | 645M | 608M | 618M | 591M | 629M | 560M | 551M | 571M | 579M | 532M | 484M | 473M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | 73M | 68M | 46M | -1.08B | -1.09B | -1.28B | 7.58B | 7.27B | 60M | 62M | 61M | 55M | 56M | -25M | 34M | 39M | 53M |
Operating Expenses | 711M | 847M | 733M | 722M | 1.08B | 1.09B | 726M | 8.19B | 677M | 651M | 691M | 621M | 606M | 627M | 645M | 566M | 523M | 526M |
Interest Expense | 48M | 43M | 34M | 29M | 28M | 27M | 27M | 27M | 27M | 28M | 27M | 28M | 27M | 28M | 30M | 30M | 30M | 30M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.58B | 10.71B | 10.12B | 9.87B | -9.45B | -9.51B | 8.73B | 8.19B | 7.88B | 7.69B | 7.91B | 7.59B | 7.69B | 7.4B | 7.22B | 6.82B | 6.53B | 6.19B |
Income Tax Expense | 70M | 92M | 95M | 112M | 105M | 98M | 73M | 87M | 107M | 106M | 22M | 77M | 86M | 86M | 33M | 48M | 58M | 77M |
Shares Outstanding (Basic) | 54.3M | 54.6M | 57.4M | 57.6M | 57.9M | 57.9M | 58M | 57.8M | 57.7M | 58M | 58M | 57.6M | 57.8M | 58M | 58M | 57.8M | 57.7M | 57.7M |
Shares Outstanding (Diluted) | 54.3M | 54.8M | 57.7M | 57.7M | 58.2M | 58.3M | 58.2M | 58.1M | 57.9M | 58M | 58.4M | 57.6M | 58.4M | 58.7M | 58.7M | 58.5M | 58.4M | 58.6M |
EPS (Basic) | 4.72 | 5.47 | 4.37 | 5.66 | 5.20 | 5.20 | 3.72 | 4.24 | 5.36 | 5.53 | 0.97 | 3.99 | 4.29 | 4.45 | 1.78 | 2.49 | 3.20 | 3.95 |
EPS (Diluted) | 4.74 | 5.45 | 4.35 | 5.65 | 5.17 | 5.16 | 3.71 | 4.22 | 5.34 | 5.53 | 0.96 | 3.99 | 4.25 | 4.40 | 1.74 | 2.46 | 3.16 | 3.89 |
EBITDA | 431M | 481M | 428M | 514M | 480M | 471M | 359M | 401M | 485M | 499M | 152M | 380M | 405M | 412M | 201M | 253M | 304M | 368M |
EBIT | 373M | 433M | 380M | 467M | 434M | 426M | 316M | 359M | 443M | 455M | 105M | 335M | 361M | 372M | 166M | 221M | 273M | 335M |
Depreciation & Amortization | 58M | 48M | 48M | 47M | 46M | 45M | 43M | 42M | 42M | 44M | 47M | 45M | 44M | 40M | 35M | 32M | 31M | 33M |